UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The new era of chelation treatments: effectiveness and safety of 10 different regimens for controlling iron overloading in thalassaemia major

British journal of haematology, 2017-09, Vol.178 (5), p.676-688

2017

Volltextzugriff (PDF)

How we manage iron overload in sickle cell patients

British journal of haematology, 2017-06, Vol.177 (5), p.703-716

2017

Volltextzugriff (PDF)

Iron chelation therapy for children with transfusion‐dependent β‐thalassemia: How young is too young?

Pediatric blood & cancer, 2024-08, Vol.71 (8), p.e31035-n/a

2024

Volltextzugriff (PDF)

Current recommendations for chelation for transfusion-dependent thalassemia

Annals of the New York Academy of Sciences, 2016-03, Vol.1368 (1), p.107-114

Kwiatkowski, Janet L.

2016

Volltextzugriff (PDF)

Chelation therapy for atherosclerotic cardiovascular disease

Cochrane database of systematic reviews, 2020-05, Vol.5 (5), p.CD002785

2020

Volltextzugriff (PDF)

Effectiveness of red blood cell exchange, partial manual exchange, and simple transfusion concurrently with iron chelation therapy in reducing iron overload in chronically transfused sickle cell anemia patients

Transfusion (Philadelphia, Pa.), 2016-07, Vol.56 (7), p.1707-1715

2016

Volltextzugriff (PDF)

Multicenter validation of spin-density projection-assisted R2-MRI for the noninvasive measurement of liver iron concentration

Magnetic resonance in medicine, 2014-06, Vol.71 (6), p.2215-2223

2014

Volltextzugriff (PDF)

Safety and efficacy of early start of iron chelation therapy with deferiprone in young children newly diagnosed with transfusion‐dependent thalassemia: A randomized controlled trial

American journal of hematology, 2018-02, Vol.93 (2), p.262-268

2018

Volltextzugriff (PDF)

Iron chelation therapy in low risk myelodysplastic syndrome

British journal of haematology, 2017-05, Vol.177 (3), p.375-387

Killick, Sally B.

2017

Volltextzugriff (PDF)

Iron‐chelating therapy with deferasirox in transfusion‐dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study

British journal of haematology, 2017-06, Vol.177 (5), p.741-750

2017

Volltextzugriff (PDF)

Management of iron overload in hemoglobinopathies: what is the appropriate target iron level?

Annals of the New York Academy of Sciences, 2016-03, Vol.1368 (1), p.95-106

2016

Volltextzugriff (PDF)

Malignancies and thalassemia: a review of the literature

Annals of the New York Academy of Sciences, 2016-03, Vol.1368 (1), p.140-148

2016

Volltextzugriff (PDF)

The management of embedded metal fragment patients and the role of chelation Therapy: A workshop of the Department of Veterans Affairs—Walter Reed National Medical Center

American journal of industrial medicine, 2020-05, Vol.63 (5), p.381-393

2020

Volltextzugriff (PDF)

Long‐term safety and efficacy of deferasirox in young pediatric patients with transfusional hemosiderosis: Results from a 5year observational study (ENTRUST)

Pediatric blood & cancer, 2017-09, Vol.64 (9), p.n/a

2017

Volltextzugriff (PDF)

Deferasirox effect on renal haemodynamic parameters in patients with transfusion‐dependent β thalassaemia

British journal of haematology, 2015-03, Vol.168 (6), p.882-890

2015

Volltextzugriff (PDF)

Combined iron chelation therapy

Annals of the New York Academy of Sciences, 2010-08, Vol.1202 (1), p.79-86

2010

Volltextzugriff (PDF)

Chelation Therapy in Patients With Cardiovascular Disease: A Systematic Review

Journal of the American Heart Association, 2022-03, Vol.11 (6), p.e024648

2022

Volltextzugriff (PDF)

Chelation therapy for neurodegenerative diseases

Medicinal research reviews, 2009-07, Vol.29 (4), p.547-570

2009

Volltextzugriff (PDF)

Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia

Cochrane database of systematic reviews, 2018-07, Vol.7 (7), p.CD011626

2018

Volltextzugriff (PDF)

Successful chelation therapy with the combination of deferasirox and deferiprone in a patient with thalassaemia major and persisting severe iron overload after single‐agent chelation therapies

British journal of haematology, 2011-09, Vol.154 (5), p.654-656

2011

Volltextzugriff (PDF)

Deferasirox for managing iron overload in people with myelodysplastic syndrome

Cochrane database of systematic reviews, 2014-10, Vol.2014 (10), p.CD007461-CD007461

2014

Volltextzugriff (PDF)

Cardiac Hemochromatosis Treated With Prolonged Extracorporeal Membrane Oxygenation Support and Chelation Therapy

Artificial organs, 2018-05, Vol.42 (5), p.575-576

2018

Volltextzugriff (PDF)

Deferiprone versus deferoxamine in thalassemia intermedia: Results from a 5‐year long‐term Italian multicenter randomized clinical trial

American journal of hematology, 2015-07, Vol.90 (7), p.634-638

2015

Volltextzugriff (PDF)

Daily alternating deferasirox and deferiprone therapy successfully controls iron accumulation in untreatable transfusion‐dependent thalassemia patients

American journal of hematology, 2018-10, Vol.93 (10), p.E338-E340

2018

Volltextzugriff (PDF)

Transfusional Iron Overload in a Cohort of Children with Sickle Cell Disease: Impact of Magnetic Resonance Imaging, Transfusion Method, and Chelation

Pediatric blood & cancer, 2016-08, Vol.63 (8), p.1414-1418

2016

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Aktive Filter

KollektionWiley-Blackwell Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(124)

Publikationsform

Artikel
(127)

Sprache

Englisch
(127)

Erscheinungsjahr

n.n

Thema

Science & Technology
(118)
Humans
(113)
Life Sciences & Biomedicine
(111)
Hematology
(61)
Chelation Therapy - Methods
(57)
Iron Chelating Agents - Therapeutic Use
(57)
Female
(55)
Male
(54)
Chelation
(53)
Adult
(47)
Iron
(35)
Chelation Therapy
(33)
Adolescent
(27)
Iron Overload
(27)
Iron Overload - Etiology
(25)
Deferoxamine - Therapeutic Use
(24)
Iron Overload - Drug Therapy
(24)
Treatment Outcome
(24)
Middle Aged
(23)
Thalassemia
(23)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The new era of chelation treatments: effectiveness and safety of 10 different regimens for controlling iron overloading in thalassaemia major

How we manage iron overload in sickle cell patients

Iron chelation therapy for children with transfusion‐dependent β‐thalassemia: How young is too young?

Current recommendations for chelation for transfusion-dependent thalassemia

Chelation therapy for atherosclerotic cardiovascular disease

Effectiveness of red blood cell exchange, partial manual exchange, and simple transfusion concurrently with iron chelation therapy in reducing iron overload in chronically transfused sickle cell anemia patients

Multicenter validation of spin-density projection-assisted R2-MRI for the noninvasive measurement of liver iron concentration

Safety and efficacy of early start of iron chelation therapy with deferiprone in young children newly diagnosed with transfusion‐dependent thalassemia: A randomized controlled trial

Iron chelation therapy in low risk myelodysplastic syndrome

Iron‐chelating therapy with deferasirox in transfusion‐dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study

Management of iron overload in hemoglobinopathies: what is the appropriate target iron level?

Malignancies and thalassemia: a review of the literature

The management of embedded metal fragment patients and the role of chelation Therapy: A workshop of the Department of Veterans Affairs—Walter Reed National Medical Center

Long‐term safety and efficacy of deferasirox in young pediatric patients with transfusional hemosiderosis: Results from a 5year observational study (ENTRUST)

Deferasirox effect on renal haemodynamic parameters in patients with transfusion‐dependent β thalassaemia

Combined iron chelation therapy

Chelation Therapy in Patients With Cardiovascular Disease: A Systematic Review

Chelation therapy for neurodegenerative diseases

Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia

Successful chelation therapy with the combination of deferasirox and deferiprone in a patient with thalassaemia major and persisting severe iron overload after single‐agent chelation therapies

Deferasirox for managing iron overload in people with myelodysplastic syndrome

Cardiac Hemochromatosis Treated With Prolonged Extracorporeal Membrane Oxygenation Support and Chelation Therapy

Deferiprone versus deferoxamine in thalassemia intermedia: Results from a 5‐year long‐term Italian multicenter randomized clinical trial

Daily alternating deferasirox and deferiprone therapy successfully controls iron accumulation in untreatable transfusion‐dependent thalassemia patients

Transfusional Iron Overload in a Cohort of Children with Sickle Cell Disease: Impact of Magnetic Resonance Imaging, Transfusion Method, and Chelation

Aktive Filter

Suchergebnisse filtern